Notice of Kidney Interagency Coordinating Committee Meeting, 46696-46697 [2016-16907]

Download as PDF 46696 Federal Register / Vol. 81, No. 137 / Monday, July 18, 2016 / Notices provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Eye Institute Special Emphasis Panel; NEI Translational Research (R24) and Patient-Oriented Mentored Training (K23) Grant Applications. Date: August 4, 2016. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, Tenleytown Ballroom II, 4300 Military Road NW., Washington, DC 20015. Contact Person: Anne E. Schaffner, Ph.D., Chief, Scientific Review Branch Division of Extramural Research, National Eye Institute, 5635 Fishers Lane, Suite 1300, MSC 9300, Bethesda, MD 20892–9300, (301) 451–2020, aes@nei.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.867, Vision Research, National Institutes of Health, HHS) Dated: July 12, 2016. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–16833 Filed 7–15–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Request for Data and Information on Technologies Used To Identify Substances With the Potential To Cause Acute Systemic Toxicity The National Toxicology Program (NTP) Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) requests data and information on approaches and/or technologies currently used to identify substances with the potential to cause acute systemic toxicity when swallowed, inhaled, or absorbed through the skin. Submitted information will be used to assess the state of the science and determine technical needs for nonanimal test methods used to evaluate the potential of chemicals to induce acute systemic toxicity. DATES: Receipt of information: Deadline is September 1, 2016. ADDRESSES: Data and information should be submitted electronically to niceatm@niehs.nih.gov. asabaliauskas on DSK3SPTVN1PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:52 Jul 15, 2016 Jkt 238001 Dr. Warren Casey, Director, NICEATM; email: warren.casey@nih.gov; telephone: (919) 316–4729. SUPPLEMENTARY INFORMATION: Background: Acute systemic toxicity tests are conducted to determine the potential for a single or short-term dose of a substance to cause illness or death when inhaled (inhalation toxicity testing), swallowed (oral toxicity testing), or absorbed through the skin (dermal toxicity testing). These tests are required by multiple regulatory agencies and can use large numbers of animals. NICEATM, which fosters the evaluation and promotion of alternative test methods for regulatory use, supports efforts to develop, validate, and implement alternative approaches for acute systemic toxicity testing that replace, reduce, or refine use of animals in testing. Request for Information: NICEATM requests data and information on approaches and/or technologies currently used to identify substances with the potential to cause acute systemic toxicity. Respondents should provide information on any activities relevant to the development or validation of alternatives to in vivo tests currently required by regulatory agencies that assess acute oral, dermal, or inhalation toxicity. Of specific interest are chemical-specific data from non-animal tests for acute systemic toxicity hazard, as well as available data on the same chemicals from in vivo acute systemic toxicity tests, such as ethical human or animal studies or accidental human exposures. Respondents to this request for information should include their name, affiliation (if applicable), mailing address, telephone, email, and sponsoring organization (if any) with their communications. The deadline for receipt of the requested information is September 1, 2016. Responses to this notice will be posted at https:// ntp.niehs.nih.gov/go/iv-data. Persons submitting responses will be identified on the Web page by name and affiliation or sponsoring organization, if applicable. Responses to this request are voluntary. No proprietary, classified, confidential, or sensitive information should be included in responses. This request for information is for planning purposes only and is not a solicitation for applications or an obligation on the part of the U.S. Government to provide support for any ideas identified in response to the request. Please note that the U.S. Government will not pay for the preparation of any information FOR FURTHER INFORMATION CONTACT: PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 submitted or for its use of that information. Background Information on NICEATM: NICEATM conducts data analyses, workshops, independent validation studies, and other activities to assess new, revised, and alternative test methods and strategies. NICEATM also provides support for the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM). The ICCVAM Authorization Act of 2000 (42 U.S.C. 285l–3) provides authority for ICCVAM and NICEATM in the development of alternative test methods. Information about NICEATM and ICCVAM is found at https:// ntp.niehs.nih.gov/go/niceatm and https://ntp.niehs.nih.gov/go/iccvam. Dated: July 12, 2016. John R. Bucher, Associate Director, National Toxicology Program. [FR Doc. 2016–16840 Filed 7–15–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Notice of Kidney Interagency Coordinating Committee Meeting The Kidney Interagency Coordinating Committee (KICC) will hold a meeting on September 19, 2016, on ‘‘CRIC and CKiD: Using longitudinal CKD cohort study findings to plan population health interventions.’’ The meeting is open to the public. DATES: The meeting will be held on September 19, 2016, 9 a.m. to 12 p.m. Individuals wanting to present oral comments must notify the contact person at least 10 days before the meeting date. ADDRESSES: The meeting will be held in the Natcher Conference Center on the NIH Campus at 9000 Rockville Pike, Bethesda, MD 20894. FOR FURTHER INFORMATION CONTACT: For further information concerning this meeting, contact Dr. Andrew S. Narva, Executive Secretary of the Kidney Interagency Coordinating Committee, National Institute of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Blvd., MSC 5458, Bethesda, MD 20892–5458, telephone: 301–594– 8864; FAX: 301–480–3510; email: healthinfo@niddk.nih.gov. SUPPLEMENTARY INFORMATION: The KICC, chaired by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), comprises members of the Department of Health and Human SUMMARY: E:\FR\FM\18JYN1.SGM 18JYN1 Federal Register / Vol. 81, No. 137 / Monday, July 18, 2016 / Notices Services and other federal agencies that support kidney-related activities, facilitates cooperation, communication, and collaboration on kidney disease among government entities. KICC meetings, held twice a year, provide an opportunity for Committee members to learn about and discuss current and future kidney programs in KICC member organizations and to identify opportunities for collaboration. The September 19, 2016 KICC meeting will focus on ‘‘CRIC and CKiD: Using longitudinal CKD cohort study findings to plan population health interventions.’’ Any member of the public interested in presenting oral comments to the Committee should notify the contact person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives or organizations should submit a letter of intent, a brief description of the organization represented, and a written copy of their oral presentation in advance of the meeting. Only one representative of an organization will be allowed to present; oral comments and presentations will be limited to a maximum of 5 minutes. Printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the Committee by forwarding their statement to the contact person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Because of time constraints for the meeting, oral comments will be allowed on a first-come, first-serve basis. Members of the public who would like to receive email notification about future KICC meetings should send a request to healthinfo@niddk.nih.gov. Dated: July 6, 2016. Camille M. Hoover, Executive Officer, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. [FR Doc. 2016–16907 Filed 7–15–16; 8:45 am] asabaliauskas on DSK3SPTVN1PROD with NOTICES BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as VerDate Sep<11>2014 17:52 Jul 15, 2016 Jkt 238001 amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Peer Review Meeting. Date: August 4, 2016. Time: 11:00 a.m. to 4:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Robert C. Unfer, Ph.D., Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers Lane, Room 3F40, MSC 9823, Rockville, MD 20892–9823, 240–669–5035, unferrc@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: July 12, 2016. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–16834 Filed 7–15–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Mental Health Services; Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given that the Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Mental Health Services (CMHS) National Advisory Council (NAC) will meet on August 24, 2016, from 9:00 a.m. to 5:00 p.m. E.D.T. The NAC will convene in both open and closed sessions. The closed portion of the meeting will include discussion and evaluation of grant review applications by SAMHSA’s Initial Review Groups, and involve an examination of confidential financial and business information as well as personal information concerning the applicants. Therefore, the meeting will PO 00000 Frm 00058 Fmt 4703 Sfmt 9990 46697 be closed to the public from 9:00 a.m. to 12:00 p.m. as determined by the Principle Deputy Administrator, in accordance with title 5 U.S.C. 552b(c)(4) and (6). The remainder of this meeting will be open to the public from 12:00 p.m. to 5:00 p.m. to include presentations on Improving Inpatient Care and Family Caregiver Challenges and Solutions. The meeting will be held at SAMHSA, 5600 Fishers Lane, 5th Floor, Conference Room A03, Rockville, MD 20857. Attendance by the public will be limited to space available. Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions should be forwarded to the contact person (below) on or before August 10, 2016. Oral presentations from the public will be scheduled at the conclusion of the meeting. The meeting can be accessed via telephone. To obtain the conference call-in number and access code, submit written or brief oral comments, or request special accommodations for persons with disabilities, please register at the SAMHSA’s Advisory Committees Web site at https://nac.samhsa.gov/ Registration/meetingsRegistration.aspx, or contact Pamela Foote (see contact information below). Committee Name: Substance Abuse and Mental Health Services Administration Center for Mental Health Services National Advisory Council. Dates/Time/Type: Wednesday, August 24, 2016, 9:00 a.m. to 12:00 p.m. EDT: CLOSED; Wednesday, August 24, 2016, 12:00 p.m. to 5:00 p.m. EDT: OPEN. Place: SAMHSA, 5600 Fishers Lane, 5th Floor, Conference Room A03, Rockville, Maryland 20857. Contact: Pamela Foote, Acting Designated Federal Official, SAMHSA CMHS National Advisory Council, 5600 Fishers Lane, Room 14E53C, Rockville, Maryland 20857, Telephone: (240) 276– 1279, Fax: (301) 480–8491, Email: pamela.foote@samhsa.hhs.gov. Summer King, Statistician, Substance Abuse and Mental Health Services Administration. [FR Doc. 2016–16829 Filed 7–15–16; 8:45 am] BILLING CODE 4162–20–P E:\FR\FM\18JYN1.SGM 18JYN1

Agencies

[Federal Register Volume 81, Number 137 (Monday, July 18, 2016)]
[Notices]
[Pages 46696-46697]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-16907]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Kidney Interagency Coordinating Committee Meeting

SUMMARY: The Kidney Interagency Coordinating Committee (KICC) will hold 
a meeting on September 19, 2016, on ``CRIC and CKiD: Using longitudinal 
CKD cohort study findings to plan population health interventions.'' 
The meeting is open to the public.

DATES: The meeting will be held on September 19, 2016, 9 a.m. to 12 
p.m. Individuals wanting to present oral comments must notify the 
contact person at least 10 days before the meeting date.

ADDRESSES: The meeting will be held in the Natcher Conference Center on 
the NIH Campus at 9000 Rockville Pike, Bethesda, MD 20894.

FOR FURTHER INFORMATION CONTACT: For further information concerning 
this meeting, contact Dr. Andrew S. Narva, Executive Secretary of the 
Kidney Interagency Coordinating Committee, National Institute of 
Diabetes and Digestive and Kidney Diseases, 6707 Democracy Blvd., MSC 
5458, Bethesda, MD 20892-5458, telephone: 301-594-8864; FAX: 301-480-
3510; email: healthinfo@niddk.nih.gov.

SUPPLEMENTARY INFORMATION: The KICC, chaired by the National Institute 
of Diabetes and Digestive and Kidney Diseases (NIDDK), comprises 
members of the Department of Health and Human

[[Page 46697]]

Services and other federal agencies that support kidney-related 
activities, facilitates cooperation, communication, and collaboration 
on kidney disease among government entities. KICC meetings, held twice 
a year, provide an opportunity for Committee members to learn about and 
discuss current and future kidney programs in KICC member organizations 
and to identify opportunities for collaboration. The September 19, 2016 
KICC meeting will focus on ``CRIC and CKiD: Using longitudinal CKD 
cohort study findings to plan population health interventions.''
    Any member of the public interested in presenting oral comments to 
the Committee should notify the contact person listed on this notice at 
least 10 days in advance of the meeting. Interested individuals and 
representatives or organizations should submit a letter of intent, a 
brief description of the organization represented, and a written copy 
of their oral presentation in advance of the meeting. Only one 
representative of an organization will be allowed to present; oral 
comments and presentations will be limited to a maximum of 5 minutes. 
Printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
Committee by forwarding their statement to the contact person listed on 
this notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person. Because of time constraints for the meeting, 
oral comments will be allowed on a first-come, first-serve basis.
    Members of the public who would like to receive email notification 
about future KICC meetings should send a request to 
healthinfo@niddk.nih.gov.

    Dated: July 6, 2016.
Camille M. Hoover,
Executive Officer, National Institute of Diabetes and Digestive and 
Kidney Diseases, National Institutes of Health.
[FR Doc. 2016-16907 Filed 7-15-16; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.